GSK : ViiV's Cabotegravir For HIV Prevention Receives Positive CHMP Opinion From EMA
24/7 08:46
(RTTNews) - ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending marketing auth...